Definitive Healthcare Corp (NASDAQ: DH) is a healthcare commercial intelligence company that provides data and analytics to organizations selling into or competing within the U.S. healthcare market. Revenue comes almost entirely from subscription fees for access to its SaaS platform, which aggregates and links data from thousands of sources into profiles of healthcare providers, life sciences companies, and related organizations. The company serves approximately 2,330 customers as of December 31, 2025 across three primary end markets: Life Sciences (biopharmaceutical and medical device companies), Provider (hospitals, health systems, and care delivery organizations), and Diversified (healthcare IT companies, staffing firms, commercial real estate firms, financial institutions, and marketing agencies). Founded in 2011 and incorporated as Definitive Healthcare Corp. in May 2021, the company completed its IPO of Class A common stock on September 17, 2021. The platform is U.S.-focused, covering what the company describes as the entire U.S. healthcare ecosystem. The company's stated defensive moat is its proprietary data platform, built through first-party research and aggregation of billions of data points.
SaaS platform providing healthcare commercial intelligence data, including modules covering sales, marketing, clinical research, product development, strategy, talent acquisition, and physician network management.
Subscription fees for SaaS-based access to healthcare commercial intelligence data; the company generates substantially all revenue from subscriptions, as disclosed in the FY2025 10-K filed 2026-02-26.
Approximately 2,330 customers as of December 31, 2025. End markets: Life Sciences (biopharmaceutical, medical device), Provider (hospitals, health systems, care delivery organizations), and Diversified (healthcare IT, staffing, commercial real estate, financial institutions, marketing and advertising agencies). Functional buyers within customer organizations include sales, marketing, clinical research, product development, strategy, and talent acquisition teams.
U.S. healthcare market focus, as described in the FY2025 10-K filed 2026-02-26. No international segment disclosed in the excerpts.
Loading...